Galena Biopharma Inc Share Price Nasdaq
Equities
US3632565046
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 69.88M 5.46B |
---|---|---|---|---|---|
Net income 2024 * | -37M -2.89B | Net income 2025 * | -38M -2.97B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.74
x | P/E ratio 2025 * |
-1.98
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.73% |
Latest transcript on Galena Biopharma Inc
Managers | Title | Age | Since |
---|---|---|---|
Angelos Stergiou
FOU | Founder | 48 | 02/04/06 |
John Burns
DFI | Director of Finance/CFO | 39 | 30/04/13 |
Andrew Elnatan
LAW | General Counsel | - | 04/01/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 28/12/17 | |
David Scheinberg
BRD | Director/Board Member | 68 | 30/11/17 |
John Varian
BRD | Director/Board Member | 64 | 28/12/17 |
1st Jan change | Capi. | |
---|---|---|
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |